Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Quentin30on Dec 17, 2024 11:01am
77 Views
Post# 36366233

RE:RE:ONCY off to another strong start in the markets

RE:RE:ONCY off to another strong start in the marketsBashing...???? I don't understand... I only asked where the partner is that we have been promised for a decade...

How is that bashing?

It would be rather nice, if ONCY would let us know what their plans are if they cannot find one... have you considered that Peladawn ? 

As for having kids diagnosed with pancreatic cancer or any other cancer, is all the more reason for shareholders to ask ONCY mgmt the question... because they certainly cannot bring Pela to market WITHOUT a partner..

At least give your brain a chance before you write next time... This company at present isn't looking very healthy.

<< Previous
Bullboard Posts
Next >>